These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22901155)

  • 1. The metabolic syndrome and risk factors for biliary tract cancer: a case-control study in China.
    Wu Q; He XD; Yu L; Liu W; Tao LY
    Asian Pac J Cancer Prev; 2012; 13(5):1963-9. PubMed ID: 22901155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.
    Tao LY; He XD; Qu Q; Cai L; Liu W; Zhou L; Zhang SM
    Liver Int; 2010 Feb; 30(2):215-21. PubMed ID: 19840244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
    Shaib YH; El-Serag HB; Nooka AK; Thomas M; Brown TD; Patt YZ; Hassan MM
    Am J Gastroenterol; 2007 May; 102(5):1016-21. PubMed ID: 17324130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological survey of biomarkers of hepatitis virus in patients with extrahepatic cholangiocarcinomas.
    Qu Z; Cui N; Qin M; Wu X
    Asia Pac J Clin Oncol; 2012 Mar; 8(1):83-7. PubMed ID: 22369448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies.
    Li H; Hu B; Zhou ZQ; Guan J; Zhang ZY; Zhou GW
    World J Surg Oncol; 2015 Apr; 13():161. PubMed ID: 25903488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma.
    Bertuccio P; Malvezzi M; Carioli G; Hashim D; Boffetta P; El-Serag HB; La Vecchia C; Negri E
    J Hepatol; 2019 Jul; 71(1):104-114. PubMed ID: 30910538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China.
    Hsing AW; Zhang M; Rashid A; McGlynn KA; Wang BS; Niwa S; Ortiz-Conde BA; Goedert JJ; Fraumeni JF; O'Brien TR; Gao YT
    Int J Cancer; 2008 Apr; 122(8):1849-53. PubMed ID: 18076042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.
    Welzel TM; Graubard BI; Zeuzem S; El-Serag HB; Davila JA; McGlynn KA
    Hepatology; 2011 Aug; 54(2):463-71. PubMed ID: 21538440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
    Welzel TM; Graubard BI; El-Serag HB; Shaib YH; Hsing AW; Davila JA; McGlynn KA
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1221-8. PubMed ID: 17689296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary tract cancer and stones in relation to chronic liver conditions: A population-based study in Shanghai, China.
    Hsing AW; Gao YT; McGlynn KA; Niwa S; Zhang M; Han TQ; Wang BS; Chen J; Sakoda LC; Shen MC; Zhang BH; Deng J; Rashid A
    Int J Cancer; 2007 May; 120(9):1981-5. PubMed ID: 17278101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological features of precancerous and early cancerous lesions of biliary tract carcinoma.
    Aishima S; Kubo Y; Tanaka Y; Oda Y
    J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):448-52. PubMed ID: 24446428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Case-control study of risk factors in cholangiocarcinoma].
    Tao LY; He XD; Cai L; Liu W; Ji WJ; Zhao L; Zhang SM
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):759-63. PubMed ID: 20021829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk.
    Chaiteerakij R; Yang JD; Harmsen WS; Slettedahl SW; Mettler TA; Fredericksen ZS; Kim WR; Gores GJ; Roberts RO; Olson JE; Therneau TM; Roberts LR
    Hepatology; 2013 Feb; 57(2):648-55. PubMed ID: 23055147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database.
    Kim BW; Oh CM; Choi HY; Park JW; Cho H; Ki M
    Gut Liver; 2019 Jan; 13(1):104-113. PubMed ID: 29938462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholelithiasis and the risk of intrahepatic cholangiocarcinoma: a meta-analysis of observational studies.
    Cai H; Kong WT; Chen CB; Shi GM; Huang C; Shen YH; Sun HC
    BMC Cancer; 2015 Nov; 15():831. PubMed ID: 26526500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
    Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
    Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignancies of the biliary tree.
    Pitt HA; Dooley WC; Yeo CJ; Cameron JL
    Curr Probl Surg; 1995 Jan; 32(1):1-90. PubMed ID: 7528652
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
    Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
    World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gallbladder and bile duct carcinoma. Biology and pathology].
    Tannapfel A; Wittekind C
    Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.